CLASS ACTION UPDATE for KODK, VXRT and LX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Back to Newsroom
Mentioned in this Article

CLASS ACTION UPDATE for KODK, VXRT and LX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Monday, September 14, 2020 4:00 PM
Share this article now
Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / September 14, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

KODK Shareholders Click Here: https://www.zlk.com/pslra-1/eastman-kodak-company-information-request-form-2?prid=9249&wire=1
VXRT Shareholders Click Here: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=9249&wire=1
LX Shareholders Click Here: https://www.zlk.com/pslra-1/lexinfintech-holdings-ltd-information-request-form?prid=9249&wire=1

* ADDITIONAL INFORMATION BELOW *

Eastman Kodak Company (NYSE:KODK)

KODK Lawsuit on behalf of: investors who purchased July 27, 2020 - August 11, 2020
Lead Plaintiff Deadline : October 13, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/eastman-kodak-company-information-request-form-2?prid=9249&wire=1

According to a filed complaint, defendants failed to disclose that the Company had granted its Executive Chairman, James Continenza, and several other Company insiders millions of dollars' worth of stock options immediately prior to the Company publicly disclosing that it had received the $765 million loan, which Defendants knew would cause Kodak's stock to immediately increase in value once the deal was announced. In addition, while in possession of this material non-public information, Continenza and other Company insiders purchased tens of thousands of the Company's shares immediately prior to the announcement, again at prices that they knew would increase exponentially once news of the loan became public.

Vaxart, Inc. (NASDAQ:VXRT)

VXRT Lawsuit on behalf of: investors who purchased June 25, 2020 - July 25, 2020
Lead Plaintiff Deadline : October 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=9249&wire=1

According to the filed complaint, during the class period, Vaxart, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.

Lexinfintech Holdings, Ltd. (NASDAQ:LX)

LX Lawsuit on behalf of: investors who purchased April 30, 2019 - August 24, 2020
Lead Plaintiff Deadline : November 9, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/lexinfintech-holdings-ltd-information-request-form?prid=9249&wire=1

According to the filed complaint, during the class period, Lexinfintech Holdings, Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) LexinFintech reported artificially low delinquency rates by giving borrowers in default new funds to make payments; (2) the Company's business model exposes shareholders to enormous losses by prioritizing Chinese lenders for off-balance sheet loans; (3) the Company exaggerated its user base; (4) the Company was facilitating direct peer to peer lending contrary to Chinese law; (5) the Company engaged in undisclosed related party transactions; (6) the Company lacked adequate internal controls; and (7) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

Levi & Korsinsky, LLP
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: